期刊
CELL BIOCHEMISTRY AND FUNCTION
卷 37, 期 1, 页码 21-30出版社
WILEY
DOI: 10.1002/cbf.3369
关键词
cancer; drug development; PROTAC; protein degradation; small molecule
资金
- National Natural Science Foundation of China [81572729, 81830092, 81872244]
- Chinese National Major Scientific Research Program [2016YFA0500301]
Currently, a new technology termed PROTAC, proteolysis targeting chimera, has been developed for inducing the protein degradation by a targeting molecule. This technology takes advantage of a moiety of targeted protein and a moiety of recognizing E3 ubiquitin ligase and produces a hybrid molecule to specifically knock down a targeted protein. During the first decade, three pedigreed groups worked on the development of this technology. To date, this technology has been extended by different groups, aiming to develop new drugs against different diseases including cancers. This review summarizes the contributions of the groups for the development of PROTAC. Significance of the study This review summarized the development of the PROTAC technology for readers and also presented the author's opinions on the application of the technology in tumor therapy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据